E. Antonioli, A. Carobbio, L. Pieri, A. Pancrazzi, P. Guglielmelli et al., Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia, Haematologica, vol.95, pp.1435-1438, 2010.

C. ;. Besses, Alvarez-Larr an, A., Mart ?nez-Avil es

S. Mojal, R. Longar-on, A. Salar, L. Florensa, S. Serrano et al., Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patients: JAK2 V617F Modulation by Hydroxyurea, British Journal of Haematology, vol.152, pp.413-419, 2011.

X. Cabagnols, F. Favale, F. Pasquier, K. Messaoudi, J. P. Defour et al., Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients, Blood, vol.127, pp.333-342, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01258942

J. Defour, I. Chachoua, C. Pecquet, and S. N. Constantinescu, Oncogenic activation of MPL/thrombopoietin receptor by 17 mutations at W515: implications for myeloproliferative neoplasms, Leukemia, vol.30, pp.1214-1216, 2016.

A. Dusa, J. Staerk, J. Elliott, C. Pecquet, H. A. Poirel et al., Substitution of pseudokinase domain residue Val-617 by large non-polar amino acids causes activation of JAK2, Journal of Biological Chemistry, vol.283, pp.12941-12948, 2008.

W. Ma, H. Kantarjian, X. Zhang, C. Yeh, Z. J. Zhang et al., Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias, The Journal of Molecular Diagnostics, vol.11, pp.49-53, 2009.

W. Ma, X. Zhang, X. Wang, Z. Zhang, C. Yeh et al., MPL mutation profile in JAK2 mutation-negative patients with myeloproliferative disorders, Diagnostic Molecular Pathology, vol.20, pp.34-39, 2011.

C. Marty, C. Saint-martin, C. Pecquet, S. Grosjean, J. Saliba et al., Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors, Blood, vol.123, pp.1372-1383, 2014.

A. J. Mead, M. J. Rugless, S. E. Jacobsen, and A. Schuh, Germline JAK2 mutation in a family with hereditary thrombocytosis, The New England Journal of Medicine, vol.366, pp.967-969, 2012.

A. J. Mead, O. Chowdhury, C. Pecquet, A. Dusa, P. Woll et al., Impact of isolated germline JAK2V617I mutation on human hematopoiesis, Blood, vol.121, pp.4156-4165, 2013.